Matsumoto H - Search Results

1

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [¹⁸F]DiFA and comparison with [¹⁸F]FMISO.

Watanabe S, Shiga T, Hirata K, Magota K, Okamoto S, Toyonaga T, Higashikawa K, Yasui H, Kobayashi J, Nishijima KI, Iseki K, Matsumoto H, Kuge Y, Tamaki N. Watanabe S, et al. Among authors: matsumoto h. EJNMMI Res. 2019 Jul 5;9(1):60. doi: 10.1186/s13550-019-0525-6. EJNMMI Res. 2019. PMID: 31278504 Free PMC article.

2

A Novel PET Probe "[¹⁸F]DiFA" Accumulates in Hypoxic Region via Glutathione Conjugation Following Reductive Metabolism.

Shimizu Y, Zhao S, Yasui H, Nishijima KI, Matsumoto H, Shiga T, Tamaki N, Ogawa M, Kuge Y. Shimizu Y, et al. Among authors: matsumoto h. Mol Imaging Biol. 2019 Feb;21(1):122-129. doi: 10.1007/s11307-018-1214-y. Mol Imaging Biol. 2019. PMID: 29845425

3

Comparative evaluation of [¹⁸F]DiFA and its analogs as novel hypoxia positron emission tomography and [¹⁸F]FMISO as the standard.

Nakata N, Kiriu M, Okumura Y, Zhao S, Nishijima KI, Shiga T, Tamaki N, Kuge Y, Matsumoto H. Nakata N, et al. Among authors: matsumoto h. Nucl Med Biol. 2019 Mar;70:39-45. doi: 10.1016/j.nucmedbio.2019.01.008. Epub 2019 Feb 8. Nucl Med Biol. 2019. PMID: 30836255

4

The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.

Kobashi N, Matsumoto H, Zhao S, Meike S, Okumura Y, Abe T, Akizawa H, Ohkura K, Nishijima K, Tamaki N, Kuge Y. Kobashi N, et al. Among authors: matsumoto h. J Nucl Med. 2016 Aug;57(8):1276-81. doi: 10.2967/jnumed.115.165811. Epub 2016 Apr 7. J Nucl Med. 2016. PMID: 27056620 Free article.

5

Controlled administration of penicillamine reduces radiation exposure in critical organs during 64Cu-ATSM internal radiotherapy: a novel strategy for liver protection.

Yoshii Y, Matsumoto H, Yoshimoto M, Furukawa T, Morokoshi Y, Sogawa C, Zhang MR, Wakizaka H, Yoshii H, Fujibayashi Y, Saga T. Yoshii Y, et al. Among authors: matsumoto h. PLoS One. 2014 Jan 22;9(1):e86996. doi: 10.1371/journal.pone.0086996. eCollection 2014. PLoS One. 2014. PMID: 24466309 Free PMC article.

6

Multiple Administrations of ⁶⁴Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts.

Yoshii Y, Matsumoto H, Yoshimoto M, Zhang MR, Oe Y, Kurihara H, Narita Y, Jin ZH, Tsuji AB, Yoshinaga K, Fujibayashi Y, Higashi T. Yoshii Y, et al. Among authors: matsumoto h. Transl Oncol. 2018 Feb;11(1):24-30. doi: 10.1016/j.tranon.2017.10.006. Epub 2017 Nov 17. Transl Oncol. 2018. PMID: 29154146 Free PMC article.

7

Evaluation of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid accumulation in low-grade glioma in chemically induced rat models: PET and autoradiography compared with morphological images and histopathological findings.

Doi Y, Kanagawa M, Maya Y, Tanaka A, Oka S, Nakata N, Toyama M, Matsumoto H, Shirakami Y. Doi Y, et al. Among authors: matsumoto h. Nucl Med Biol. 2015 Aug;42(8):664-72. doi: 10.1016/j.nucmedbio.2015.04.008. Epub 2015 May 7. Nucl Med Biol. 2015. PMID: 26022202

8

⁶⁴Cu-ATSM internal radiotherapy to treat tumors with bevacizumab-induced vascular decrease and hypoxia in human colon carcinoma xenografts.

Yoshii Y, Yoshimoto M, Matsumoto H, Furukawa T, Zhang MR, Inubushi M, Tsuji AB, Fujibayashi Y, Higashi T, Saga T. Yoshii Y, et al. Among authors: matsumoto h. Oncotarget. 2017 Sep 28;8(51):88815-88826. doi: 10.18632/oncotarget.21323. eCollection 2017 Oct 24. Oncotarget. 2017. PMID: 29179478 Free PMC article.

9

(64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.

Yoshii Y, Furukawa T, Matsumoto H, Yoshimoto M, Kiyono Y, Zhang MR, Fujibayashi Y, Saga T. Yoshii Y, et al. Among authors: matsumoto h. Cancer Lett. 2016 Jun 28;376(1):74-82. doi: 10.1016/j.canlet.2016.03.020. Epub 2016 Mar 17. Cancer Lett. 2016. PMID: 26996296

10

Preclinical Pharmacokinetic and Safety Studies of Copper-Diacetyl-Bis(N⁴-Methylthiosemicarbazone) (Cu-ATSM): Translational Studies for Internal Radiotherapy.

Matsumoto H, Yoshii Y, Baden A, Kaneko E, Hashimoto H, Suzuki H, Kawamura K, Zhang MR, Higashi T, Kurihara H. Matsumoto H, et al. Transl Oncol. 2019 Sep;12(9):1206-1212. doi: 10.1016/j.tranon.2019.05.017. Epub 2019 Jun 25. Transl Oncol. 2019. PMID: 31252311 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,058 results

Search Page

Filters